Page 3 - Garyl Crocker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Garyl crocker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Garyl Crocker Today - Breaking & Trending Today

Merrimack Pharmaceuticals (NASDAQ:MACK) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Shares of NASDAQ MACK opened at $6.39 on Friday. The stock has a market capitalization of $85.69 million, a P/E ratio of -35.50 and a […] ....

United Kingdom , United States , United Kingdom General , Garyl Crocker , Radnor Capital Management , Securities Exchange Commission , Merrimack Pharmaceuticals Company Profile Get Rating , Merrimack Pharmaceuticals , Yakira Capital Management Inc , Blackrock Inc , Citadel Advisors , Merrimack Pharmaceuticals Inc , Get Rating , Exchange Commission , Director Noah , Capital Management , Pharmaceuticals Company Profile , Nasdaq Mack , Initiated Coverage , Stocknews Com ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Merrimack Pharmaceuticals stock opened at $6.14 on Friday. The firm has a market capitalization of $82.34 million, a P/E ratio of -34.11 and a beta of […] ....

United Kingdom , United States , United Kingdom General , Garyl Crocker , Radnor Capital Management , Merrimack Pharmaceuticals Company Profile Get Rating , Merrimack Pharmaceuticals , Yakira Capital Management Inc , Blackrock Inc , Merrimack Pharmaceuticals Inc , Get Rating , Director Noah , Street Corp , Capital Management , Yakira Capital Management , Pharmaceuticals Company Profile , Nasdaq Mack , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on Merrimack Pharmaceuticals (NASDAQ:MACK)

StockNews.com initiated coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $6.74 on Friday. Merrimack Pharmaceuticals has a twelve month low of $3.66 and a twelve month high of $7.97. The […] ....

United Kingdom , United States , Garyl Crocker , Morgan Stanley , Radnor Capital Management , Securities Exchange Commission , Merrimack Pharmaceuticals , Yakira Capital Management Inc , Merrimack Pharmaceuticals Get Rating , Citadel Advisors , Merrimack Pharmaceuticals Inc , Get Rating , Exchange Commission , Director Noah , Capital Management , Street Corp , Yakira Capital Management , Nasdaq Mack , Initiated Coverage , Stocknews Com ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report report published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. NASDAQ:MACK opened at $6.74 on Friday. Merrimack Pharmaceuticals has a 12 month low of $3.66 and a 12 month high of $7.97. The company […] ....

United Kingdom , United States , Garyl Crocker , Morgan Stanley , Radnor Capital Management , Merrimack Pharmaceuticals , Yakira Capital Management Inc , Merrimack Pharmaceuticals Get Rating , Citadel Advisors , Merrimack Pharmaceuticals Inc , Get Rating , Director Noah , Capital Management , Street Corp , Yakira Capital Management , Nasdaq Mack , Initiated Coverage , Stocknews Com ,

Nexus Spine Announces Availability of Novel Implants for Spine Surgery


Nexus Spine Announces Availability of Novel Implants for Spine Surgery
Ground-breaking Compliant Mechanism Technology Reduces Pain, Speeds Recovery, and Simplifies Surgery
New Tranquil Interbody Spacer Allows Titanium to Behave Like Spinal Bone to Improve Spinal Stability, Speed Healing, Ameliorate Subsidence and Eliminate Pain
Novel PressON Lumbar Fixation System Provides Patient-specific Compositions to Eliminate the Painful Stresses Caused by Rod-bending During Implantation of Traditional Systems
News provided by
Share this article
Share this article
SALT LAKE CITY, Feb. 24, 2021 /PRNewswire/  Nexus Spine, a developer of medical instruments and implants for spinal surgery, today announced the broad availability of its novel compliant-mechanism based systems for use in spinal surgeries; specifically, PressON, which is a patient-specific fixation system for stabilizing the human spine, and Tranquil, which is a flexible titanium device for interbody f ....

Jeffreys Hoskins , Garyl Crocker , John Edwards , Adam Echols , David Hawkes , Orthopedic Institute Of Dayton , Nexus Spine , Orthopedic Institute , ஜெஃப்ரீஸ் ஹோஸ்கின்ஸ் , ஜான் எட்வர்ட்ஸ் , ஆடம் எதிரொலிகள் , டேவிட் பருந்துகள் , எலும்பியல் நிறுவனம் ஆஃப் பகல் , நெக்ஸஸ் முதுகெலும்பு , எலும்பியல் நிறுவனம் ,